These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2561651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential distribution of muscarinic receptor subtypes and their regulation by G-protein in rat brain.
    Wei JW, Hung WC.
    Gen Pharmacol; 1990; 21(4):471-6. PubMed ID: 2116347
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
    Monsma FJ, Abood LG, Hoss W.
    Biochem Pharmacol; 1988 Jun 15; 37(12):2437-43. PubMed ID: 2839194
    [Abstract] [Full Text] [Related]

  • 5. Effects of calcium ionophore A23187 and calcium antagonists on 32Pi incorporation into polyphosphoinositides of rat cortical synaptosomes.
    Wei JW, Wang EK.
    Int J Biochem; 1987 Jun 15; 19(7):607-11. PubMed ID: 3040486
    [Abstract] [Full Text] [Related]

  • 6. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 15; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 7. Guanine nucleotides have a direct inhibitory effect on polyphosphoinositide turnover in rat cortical synaptosomes.
    Wei JW, Hung WC.
    Int J Biochem; 1990 Dec 15; 22(5):507-11. PubMed ID: 2161358
    [Abstract] [Full Text] [Related]

  • 8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 15; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 9. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
    Richards MH.
    Br J Pharmacol; 1990 Apr 15; 99(4):753-61. PubMed ID: 1694463
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the coupling of muscarinic M3 receptor to cyclic AMP formation and poly-phosphatidylinositol turnover in rat salivary glands.
    Wei JW, Yeh SR, Wang EK.
    Chin J Physiol; 1991 Apr 15; 34(3):303-15. PubMed ID: 1667096
    [Abstract] [Full Text] [Related]

  • 11. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May 15; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 12. Specificity of methoctramine in blocking muscarinic receptors which inhibit adenylate cyclase in cerebellar granule cells.
    McLeskey SW, Fischofer-Hahn C, Takahashi K, Wojcik WJ.
    Neuropharmacology; 1990 Sep 15; 29(9):853-60. PubMed ID: 2293064
    [Abstract] [Full Text] [Related]

  • 13. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX, Roeske WR, Gulya K, Wang W, Yamamura HI.
    Life Sci; 1987 Oct 05; 41(14):1751-60. PubMed ID: 3657382
    [Abstract] [Full Text] [Related]

  • 14. Effect of in vivo exposure to hypoxia on muscarinic cholinergic receptor-coupled phosphoinositide turnover in the rat brain.
    Ninomiya H, Taniguchi T, Fujiwara M, Shimohama S, Kameyama M.
    Brain Res; 1989 Mar 13; 482(1):109-21. PubMed ID: 2539879
    [Abstract] [Full Text] [Related]

  • 15. Membrane depolarization and carbamoylcholine stimulate phosphatidylinositol turnover in intact nerve terminals.
    Audigier SM, Wang JK, Greengard P.
    Proc Natl Acad Sci U S A; 1988 Apr 13; 85(8):2859-63. PubMed ID: 3357896
    [Abstract] [Full Text] [Related]

  • 16. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
    Adem A, Sabbagh M, Nordberg A.
    J Neural Transm; 1988 Apr 13; 72(1):11-8. PubMed ID: 3379385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 13; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 19. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
    Nilvebrant L.
    Acta Pharmacol Toxicol (Copenh); 1986 Jul 13; 59 Suppl 1():1-45. PubMed ID: 3524114
    [Abstract] [Full Text] [Related]

  • 20. (+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.
    Katsura M, Iino T, Kuriyama K.
    J Pharmacol Exp Ther; 1993 Oct 13; 267(1):192-6. PubMed ID: 8229745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.